Dr. Huppert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
Fl 3
San Francisco, CA 94143Phone+1 415-353-7070Fax+1 415-502-1976
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 2018
- Harvard Medical SchoolClass of 2015
Certifications & Licensure
- CA State Medical License 2017 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Hormone Receptor Positive HER2-negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple Negative Breast Cancers.Alejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, Christina Yau, Michal Marczyk
Clinical Cancer Research. 2024-11-19 - 3 citationsNeoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer.Alejandro Ríos-Hoyo, Erin Cobain, Laura A Huppert, Peter D Beitsch, Thomas A Buchholz
Journal of Clinical Oncology. 2024-08-01 - Demographic and clinical characteristics of patients with metastatic breast cancer and leptomeningeal disease: a single center retrospective cohort study.Laura A Huppert, Samantha Fisch, Elene Tsopurashvili, Sai Sahitha Somepalle, Mia Salans
Breast Cancer Research and Treatment. 2024-08-01
Press Mentions
- UCSF Cancer Specialists to Present Clinical Findings at Major ConferenceJune 2nd, 2022
- Adding Immunotherapy to Neoadjuvant Chemo Boosts pCR in HR-Positive Breast CancerDecember 9th, 2023
- No Benefit to Adjuvant-Only Immunotherapy in Early TNBCDecember 9th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: